The Recall Desk

Manufacturer

AstraZeneca Pharmaceuticals, LP

5 recalls in our database name AstraZeneca Pharmaceuticals, LP as the manufacturing or recalling firm.

What the numbers show

Total
5
Critical
0
Severe
3
Most recent
2018-03-14

Of the 5 recalls from AstraZeneca Pharmaceuticals, LP we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 3 (60%) are Severe.

About this listing

The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.

Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.

1–5 of 5

  • LowFDA (Drugs)·D-0585-2018·2018-03-14

    AstraZeneca Recalls Lynparza Capsules Due to Quality Attribute Deviation

    AstraZeneca is recalling 18,056 bottles of Lynparza (olaparib) capsules 50 mg due to elevated levels of a specific quality attribute.

    Product
    Lynparza (olaparib) capsules 50 mg, 112 count bottles, Rx only, Manufactured for: Astra Zeneca Pharmaceuticals LP Wilmington, DE 19850 by: Patheon Pharmaceuticals, Inc. Cincinnati OH 45237 Product of Switzerland NDC 0310-0657-58
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-0781-2016·2016-03-30

    AstraZeneca Recalls Tudorza Pressair Inhalers Due to Defective Delivery System

    AstraZeneca is recalling Tudorza Pressair inhalers because some units have actuation counters set to a number other than 60.

    Product
    Tudorza Pressair (aclindinium bromide inhalation powder), 400 mcg per actuation, 60 Metered Doses per Inhaler, Rx Only. Manufactured for: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850. Manufactured by: Forest Laboratories, Ireland Limited, Dublin 17 Ireland. Product of Spa
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1141-2015·2015-06-24

    NEXIUM Capsules Recalled Due to Presence of SEROQUEL XR Tablets

    AstraZeneca is recalling NEXIUM capsules because a retail pharmacist found SEROQUEL XR tablets in an unopened bottle.

    Product
    NEXIUM¿ (esomeprazole magnesium), Delayed-Release capsules, 20 mg, 30-count bottle, Rx only, Manufactured for AstraZeneca LLC, Wilmington, Distributed by AstraZeneca, AB, Sodertalje, Sweden. NDC 00186-5020-31.
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-840-2013·2013-08-14

    AstraZeneca Recalls Merrem I.V. Vials Due to Precipitate Presence

    AstraZeneca is recalling specific lots of Merrem I.V. (meropenem) because of precipitate presence, which may prevent the medication from mixing completely.

    Product
    MERREM I.V. (meropenem for injection), 1 g meropenem equivalent, 30 mL vial, Rx only, Mfd for: AstraZeneca Pharmaceuticals LP, Wilmington, DE by ACS Dobfar SpA Viale Addetta, Tribiano, Milano Italy NDC 0310 0321 30
    Category
    Drug
    Distribution
    1 state